- Home
- VICR vs LIVN Comparison
VICR vs LIVN Comparison
Compare VICR & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICR
- LIVN
- Stock Information
- Founded
- VICR 1981
- LIVN 1987
- Country
- VICR United States
- LIVN United Kingdom
- Employees
- VICR N/A
- LIVN N/A
- Industry
- VICR Industrial Machinery/Components
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VICR Technology
- LIVN Health Care
- Exchange
- VICR Nasdaq
- LIVN Nasdaq
- Market Cap
- VICR 2.3B
- LIVN 2.1B
- IPO Year
- VICR N/A
- LIVN 1993
- Fundamental
- Price
- VICR $48.63
- LIVN $52.21
- Analyst Decision
- VICR Hold
- LIVN Strong Buy
- Analyst Count
- VICR 2
- LIVN 7
- Target Price
- VICR $43.00
- LIVN $59.71
- AVG Volume (30 Days)
- VICR 278.1K
- LIVN 544.9K
- Earning Date
- VICR 10-21-2025
- LIVN 10-29-2025
- Dividend Yield
- VICR N/A
- LIVN N/A
- EPS Growth
- VICR 576.06
- LIVN N/A
- EPS
- VICR 1.45
- LIVN N/A
- Revenue
- VICR $379,346,000.00
- LIVN $1,309,329,000.00
- Revenue This Year
- VICR $20.25
- LIVN $10.10
- Revenue Next Year
- VICR $4.82
- LIVN $7.75
- P/E Ratio
- VICR $33.54
- LIVN N/A
- Revenue Growth
- VICR 2.46
- LIVN 8.23
- 52 Week Low
- VICR $38.93
- LIVN $32.48
- 52 Week High
- VICR $65.70
- LIVN $58.91
- Technical
- Relative Strength Index (RSI)
- VICR 44.24
- LIVN 44.91
- Support Level
- VICR $48.60
- LIVN $49.29
- Resistance Level
- VICR $50.17
- LIVN $54.25
- Average True Range (ATR)
- VICR 1.87
- LIVN 1.41
- MACD
- VICR -0.49
- LIVN -0.36
- Stochastic Oscillator
- VICR 14.03
- LIVN 43.37
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.